Literature DB >> 1176875

Differentiation in vitro of innervated tail regenerates in larval Ambystoma.

M Globus, R Liversage.   

Abstract

Larval Ambystoma tail regenerates, innervated by the intact spinal cord, were cultured with their epidermal covering in modified Parker's medium (CMRL-1415) and the morphological integrity of the explanted regenerates was maintained with consistent success. The results show that the larval urodele tail blastema is capable of undergoing growth and differentiation when isolated in vitro and regeneration follows the normal in vivo pattern. A diffuse aggregate of blastema cells, which extended caudally from the cut end of the notochord at the time of explantation, underwent differentiation in vitro in the presence of the regenerating spinal cord. The importance of the nerve in regeneration is discussed in relation to the in vitro system.

Entities:  

Mesh:

Year:  1975        PMID: 1176875

Source DB:  PubMed          Journal:  J Embryol Exp Morphol        ISSN: 0022-0752


  5 in total

1.  Amputation-induced reactive oxygen species signaling is required for axolotl tail regeneration.

Authors:  Nour W Al Haj Baddar; Adarsh Chithrala; S Randal Voss
Journal:  Dev Dyn       Date:  2018-12-21       Impact factor: 3.780

2.  In vitro studies of the influence of prolactin on tail regeneration in the adult newtNotophthalmus viridescens.

Authors:  Richard A Liversage; Wendy E Stewart; Danielle S McLaughlin
Journal:  Wilehm Roux Arch Dev Biol       Date:  1984-11

3.  Axoplasmic transport in regenerating limbs of Ambystoma maculatum larvae.

Authors:  S R Scadding; R A Liversage
Journal:  Experientia       Date:  1979-02-15

4.  Selection of a chemically defined medium for culturing adult newt forelimb regenerates.

Authors:  M E Conn; G E Dearlove; M H Dresden
Journal:  In Vitro       Date:  1979-06

5.  A novel amniote model of epimorphic regeneration: the leopard gecko, Eublepharis macularius.

Authors:  Katherine E McLean; Matthew K Vickaryous
Journal:  BMC Dev Biol       Date:  2011-08-16       Impact factor: 1.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.